GeneThera, Inc.
GTHR · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $816 | $288 | $251 | $313 |
| - Cash | $0 | $0 | $5 | $5 |
| + Debt | $811 | $812 | $822 | $1,217 |
| Enterprise Value | $1,628 | $1,100 | $1,068 | $1,525 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$5 | -$5 | -$5 | -$5 |
| % Margin | – | – | – | – |
| EBITDA | -$1,004 | -$735 | -$484 | -$3,273 |
| % Margin | – | – | – | – |
| Net Income | -$1,011 | -$774 | -$518 | -$4,045 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.04 | -0.04 | -0.015 | -0.11 |
| % Growth | -0.5% | -161.8% | 86.2% | – |
| Operating Cash Flow | -$9 | -$5 | $0 | -$463 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$9 | -$5 | $0 | -$463 |